Pharmaceutical Business review

Alitair benzonatate formulation now eligible for Rx-to-OTC switch

Alitair provided additional details regarding its ‘398 patent specific to formulations of benzonatate.

At present, benzonatate is the only non-narcotic prescription cough product available, according to the company

The tablet eliminates the potential for numbing, thus reducing or eliminating the danger of choking.